# Cluster5-1 Analysis

## Proteins: 

ASPH, ATP2A1, BCAP31, CALR, CALU, CHM, CYFIP2, DNAJB11, ESYT1, FKBP8, GCG, GDAP2, IKBIP, KCTD20, KTN1, LRRC59, MOGS, NSDHL, P4HB, PDIA6, RCN1, SLC39A7, SMAP2, SOAT1, STC2, VAPA, VAPB, VIP, ZSCAN21

Title: Endoplasmic Reticulum Protein Interaction System

Summary: The Endoplasmic Reticulum Protein Interaction System is a complex of proteins that are primarily localized to the endoplasmic reticulum (ER) and involved in various cellular processes such as protein folding, calcium ion homeostasis, and response to ER stress. The system comprises 29 human proteins, including ASPH, ATP2A1, BCAP31, CALR, CALU, CHM, CYFIP2, DNAJB11, ESYT1, FKBP8, GCG, GDAP2, IKBIP, KCTD20, KTN1, LRRC59, MOGS, NSDHL, P4HB, PDIA6, RCN1, SLC39A7, SMAP2, SOAT1, STC2, VAPA, VAPB, VIP, and ZSCAN21. The majority of these proteins are involved in protein binding, and many are also associated with the ER membrane, cytosol, and plasma membrane. Key biological processes performed by this system include protein folding, intracellular calcium ion homeostasis, and response to ER stress. Given the cellular location and function of these proteins, the proposed name for this system is the Endoplasmic Reticulum Protein Interaction System.

References:

1. [The Unfolded Protein Response: Controlling Cell Fate Decisions Under ER Stress and Beyond](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563388/)
2. [Endoplasmic Reticulum Stress and the Unfolded Protein Response: Targeting the Achilles Heel of Multiple Myeloma](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076149/)
3. [Calcium signaling and the secretory activity of the endoplasmic reticulum](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650686/)
4. [Protein folding in the endoplasmic reticulum](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683408/)
5. [Endoplasmic Reticulum-Plasma Membrane Contact Sites](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865085/)

## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| protein binding | 26 | ASPH, ATP2A1, BCAP31, CALR, CALU, CHM, CYFIP2, DNAJB11, ESYT1, FKBP8, GCG, GDAP2, IKBIP, KTN1, LRRC59, NSDHL, P4HB, PDIA6, RCN1, SLC39A7, SMAP2, SOAT1, VAPA, VAPB, VIP, ZSCAN21 |
| endoplasmic reticulum | 20 | ASPH, BCAP31, CALR, CALU, DNAJB11, ESYT1, FKBP8, IKBIP, KTN1, LRRC59, MOGS, NSDHL, P4HB, PDIA6, RCN1, SLC39A7, SOAT1, STC2, VAPA, VAPB |
| endoplasmic reticulum membrane | 17 | ASPH, ATP2A1, BCAP31, CALR, CALU, ESYT1, FKBP8, IKBIP, KTN1, LRRC59, MOGS, NSDHL, PDIA6, SLC39A7, SOAT1, VAPA, VAPB |
| membrane | 14 | ATP2A1, BCAP31, CALR, CALU, CYFIP2, DNAJB11, ESYT1, FKBP8, IKBIP, KTN1, LRRC59, MOGS, SLC39A7, SOAT1 |
| cytosol | 9 | BCAP31, CALR, CHM, CYFIP2, FKBP8, P4HB, PDIA6, SMAP2, VAPA |
| endoplasmic reticulum lumen | 9 | CALR, CALU, DNAJB11, GCG, KTN1, P4HB, PDIA6, RCN1, STC2 |
| plasma membrane | 8 | ASPH, BCAP31, ESYT1, GCG, KTN1, PDIA6, VAPA, VAPB |
| cytoplasm | 7 | CALR, CHM, CYFIP2, KCTD20, LRRC59, SMAP2, VAPB |
| calcium ion binding | 6 | ASPH, ATP2A1, CALR, CALU, ESYT1, RCN1 |
| protein folding | 6 | CALR, DNAJB11, FKBP8, MOGS, P4HB, PDIA6 |
| extracellular region | 5 | CALR, CALU, GCG, P4HB, VIP |
| extracellular space | 5 | CALR, DNAJB11, GCG, PDIA6, STC2 |
| nucleus | 5 | CALR, CHM, CYFIP2, DNAJB11, ZSCAN21 |
| Golgi apparatus | 5 | CALR, CALU, SLC39A7, STC2, VAPB |
| extracellular exosome | 5 | CALR, CYFIP2, MOGS, P4HB, PDIA6 |
| intracellular calcium ion homeostasis | 4 | ATP2A1, CALR, STC2, VAPB |
| response to endoplasmic reticulum stress | 4 | ATP2A1, BCAP31, P4HB, PDIA6 |
| endoplasmic reticulum to Golgi vesicle-mediated transport | 4 | BCAP31, P4HB, VAPA, VAPB |
| RNA binding | 4 | CALR, KTN1, LRRC59, P4HB |
| perinuclear region of cytoplasm | 4 | CALR, CYFIP2, STC2, VAPA |
| cadherin binding | 4 | KTN1, LRRC59, VAPA, VAPB |
| protein homodimerization activity | 3 | ATP2A1, STC2, VAPB |
| mitochondrion | 3 | ATP2A1, BCAP31, FKBP8 |
| apoptotic process | 3 | BCAP31, CYFIP2, FKBP8 |
| spermatogenesis | 3 | BCAP31, CALR, ZSCAN21 |
| protein folding in endoplasmic reticulum | 3 | CALR, P4HB, VAPA |
| melanosome | 3 | CALU, P4HB, PDIA6 |
| endoplasmic reticulum chaperone complex | 3 | DNAJB11, P4HB, PDIA6 |
| identical protein binding | 3 | ESYT1, FKBP8, GCG |
| metal ion binding | 3 | FKBP8, SMAP2, ZSCAN21 |
| negative regulation of apoptotic process | 3 | FKBP8, GCG, VIP |
| hormone activity | 3 | GCG, STC2, VIP |
| enzyme binding | 3 | P4HB, STC2, VAPB |
| protein heterodimerization activity | 3 | P4HB, VAPA, VAPB |
|  proteolysis | 2 | ASPH, CYFIP2 |
| activation of cysteine-type endopeptidase activity | 2 | ASPH, CYFIP2 |
| sarcoplasmic reticulum membrane | 2 | ASPH, ATP2A1 |
| negative regulation of endoplasmic reticulum calcium ion concentration | 2 | ATP2A1, BCAP31 |
|  mitochondrial calcium ion concentration | 2 | ATP2A1, BCAP31 |
| Golgi membrane | 2 | BCAP31, VAPA |
| lipid droplet | 2 | BCAP31, NSDHL |
| endoplasmic reticulum-Golgi intermediate compartment membrane | 2 | BCAP31, CALR |
| lumenal side of endoplasmic reticulum membrane | 2 | BCAP31, CALR |
| integrin binding | 2 | CALR, P4HB |
| protein folding chaperone | 2 | CALR, FKBP8 |
| unfolded protein binding | 2 | CALR, DNAJB11 |
|  DNA-templated transcription | 2 | CALR, ZSCAN21 |
|  cell population proliferation | 2 | CALR, VIP |
|  gene expression | 2 | CALR, FKBP8 |
|  substrate adhesion-dependent cell spreading | 2 | CALR, P4HB |
| nuclear envelope | 2 | CALR, LRRC59 |
| focal adhesion | 2 | CALR, P4HB |
| external side of plasma membrane | 2 | CALR, P4HB |
| sarcoplasmic reticulum lumen | 2 | CALR, CALU |
| GTPase activator activity | 2 | CHM, SMAP2 |
| small GTPase binding | 2 | CHM, CYFIP2 |
| neuron projection | 2 | CYFIP2, VIP |
| signaling receptor binding | 2 | DNAJB11, GCG |
| phospholipid transport | 2 | ESYT1, VAPA |
| endoplasmic reticulum-plasma membrane tethering | 2 | ESYT1, VAPB |
| smoothened signaling pathway | 2 | FKBP8, NSDHL |
| camera-type eye development | 2 | FKBP8, RCN1 |
| protein-containing complex | 2 | FKBP8, P4HB |
| G protein-coupled receptor signaling pathway | 2 | GCG, VIP |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway | 2 | GCG, VIP |
| cholesterol metabolic process | 2 | NSDHL, SOAT1 |
| protein disulfide isomerase activity | 2 | P4HB, PDIA6 |
| protein-disulfide reductase activity | 2 | P4HB, PDIA6 |
| cellular response to hypoxia | 2 | P4HB, STC2 |
| endoplasmic reticulum-Golgi intermediate compartment | 2 | P4HB, PDIA6 |
| nucleoplasm | 2 | SLC39A7, SMAP2 |
| endoplasmic reticulum unfolded protein response | 2 | STC2, VAPB |
| microtubule binding | 2 | VAPA, VAPB |
| FFAT motif binding | 2 | VAPA, VAPB |
| endoplasmic reticulum organization | 2 | VAPA, VAPB |
| COPII-coated vesicle budding | 2 | VAPA, VAPB |
| endoplasmic reticulum exit site | 2 | VAPA, VAPB |

